View image online ( 22-HVI-3411464_GLP-1-and-GIP-dual-agonism_650x450 Researchers and clinicians have long recognized a web of cause-and-effect relationships within the triad of cardiovascular disease (CVD), diabetes and obesity
While daily supplementation is common, specific dosages and frequencies should be determined in consultation with a healthcare provider, especially for those with underlying health issues or those taking other medications
Irritable bowel syndrome and mental health comorbidity - approach to multidisciplinary management
Dont miss Food Navigators broadcast series on Weight Management Join industry leaders and scientists on November 13 & 19 as we explore how the rise of GLP-1 weight-loss drugs is disrupting the food & beverage space and uncover how functional foods, bioactive ingredients and next-gen formulations can reshape satiety, metabolism and brand opportunity
Eden will review your goals, medications, health history, current protocols, and whether peptide therapy is clinically appropriate before recommending a specific page, protocol, or next step
But the Wegovy pill is also covered, along with Foundayo, which is orforglipron